The SCL-1 is a slender penetrating weapon — functionally a reinforced spike 22cm in length — constructed from a non-conductive ceramic composite sheath over a tungsten-alloy core that serves as an electrode. Upon penetration of the target's skin, the weapon delivers a precisely directed electrical current along the insertion channel, propagating through tissue fluid and targeting conductive pathways — nerves, blood vessels, and implant wiring — rather than simply burning the entry point. The result is a deeply internal electrical injury that causes systemic nerve disruption, implant damage, and in sustained contact, cardiac and neurological cascade effects that are diagnostically consistent with medical emergencies rather than assault.

The SCL-1 was developed within LAZARUS PHARMACEUTICALS' research division as a tool for studying in-vivo electrical propagation through augmented tissue — a legitimate research application that was quietly repurposed. The weapon is powered by a slim handle unit that houses a compressed capacitor bank, delivering between one and five joules of current per activation with a charge cycle of approximately 0.4 seconds. The handle is designed to resemble a medical injector at casual inspection, and the ceramic sheath provides no metallic signature under standard scanner profiles.

The weapon's most controversial feature is its documented effectiveness against augmented individuals specifically. Neural implants, subdermal communication arrays, and myoelectric muscle enhancers all provide additional conductive pathways that amplify internal current propagation, meaning the SCL-1 causes significantly greater damage to augmented targets than to unaugmented ones. This inversion of the typical augmentation-as-protection dynamic has made the weapon both feared and sought after in contexts where augmented operatives represent the primary threat.